Baselayer, a San Francisco startup helping financial institutions verify businesses and assess fraud risk, has raised $35 million in Series A funding led by M13. The round brings total funding to approximately $40 million since its 2023 launch. The company serves over 2,000 US financial institutions and claims to have prevented more than $1 billion in fraud losses. Baselayer reached eight figures in revenue in under two years. Alongside the funding, Baselayer launched its Agentic Identity Suite to verify AI agents acting on behalf of businesses. The "Know Your Agent" system aims to determine whether AI agents are authorised to complete transactions like purchases or account openings. Co-founder Jonathan Awad said AI has made fraud easier to scale, operating continuously at low cost. The company is partnering with payment processors and fraud-detection providers including FIS, Prove, and Socure to establish its credential system.

Ayble Health, an AI-enabled virtual digestive health clinic, has closed an oversubscribed $16 million Series A round led by Neon. The funding brings the Boston-based company's total capital raised to over $27 million. The company plans to expand its services beyond gastrointestinal conditions into autoimmune health. Ayble now covers 80 million Americans through partnerships with payers, employers, and health systems, and is in-network with most commercial health plans. Ayble's multidisciplinary care model combines GI specialists, dietitians, behavioural health experts, and AI technology. The company has published 16 peer-reviewed clinical studies and reports an average 47% improvement in GI symptoms for patients within four weeks. Founder Sam Jactel, who has inflammatory bowel disease, said the funding will deepen AI precision care capabilities whilst extending services to autoimmune conditions.

Flexspace today announced the launch of a corporate solution for hybrid-remote companies providing employees a seamlessly integrated platform to discover, bo...